All Posts: Georgetown Lombardi
-
With a New ‘Map’ of Cells, Georgetown Cancer Researchers Chart a Course to More Effective Treatment
Faculty and students from Biomedical Graduate Education programs, the School of Medicine and Lombardi Comprehensive Cancer Center are developing a new technique that could revolutionize the way cancers are tracked and treated. Instead of invasive surgical biopsies or time-consuming scans, clinicians could use simple blood tests to determine where the cancer is and whether it is responding to treatment.
Category: GUMC Stories
-
Tumor Biology Student Sidharth Jain Combines Discovery and Care on MD/PhD Path
As an MD/PhD in Tumor Biology student, Sidharth Jain works between two worlds of health science. On the PhD side, lab research, data analysis and discovery; on the MD side, patients fighting for their lives.
Category: GUMC Stories
-
Celebrating Its 15th Anniversary, Ruesch Center Honors Founder
Since its establishment in September 2009, the Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers at Georgetown’s Lombardi Comprehensive Cancer Center has been dedicated to advancing transformative research to save lives. At the Luminary Awards in GI Cancer, attendees honored the countless contributions of Jeanne Ruesch, chair of the Ruesch Family Foundation and founder of the Ruesch Center.
Category: GUMC Stories
-
Oral Health Scholars Raise Awareness About the Relationship Between Oral and Systemic Health
While oral health is often treated as something separate from overall health, it can act as an early warning system for serious conditions, including cancer and heart disease. With funding from the George E. Richmond Foundation, researchers at Georgetown’s Lombardi Comprehensive Cancer Center are training students to educate their communities about the importance of oral health.
Category: GUMC Stories
-
Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations
Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung cancer has alterations in a gene called ALK.
Category: News Release
-
Months After Chemotherapy, MD/PhD Student Bikes 50 Miles for Cancer Research
A year and a half into medical school at Georgetown, Bryan Weselman was diagnosed with cancer. Now, he’s researching cancer to improve treatment for other patients.
Category: GUMC Stories
-
Competitive Cancer Research Internship Program Offers Rewarding Experiences for Undergraduates
This year, 10 rising sophomores, juniors and seniors from colleges and universities across the country participated in the 10-week full-time Diversity in Cancer Research Undergraduate Internship Program, which affords students the opportunity to get a broad view of what cancer research is.
Category: GUMC Stories
-
For This Medical Student, Her Cancer Research Is for Her Little Sister
Ritu Amarnani (M’27), a second-year medical student, spent this summer researching cancer care at Georgetown’s Lombardi Comprehensive Cancer Center. She turned her career focus toward medicine after her younger sister’s cancer diagnosis and death.
Category: GUMC Stories
-
Identifying ‘Stealth’ Sources of Saturated Fat, Added Sugar in the Diet
A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults unknowingly overdo it on saturated fat and added sugar in their daily diet, a new study by a team including Georgetown Lombardi researchers suggests.
Category: GUMC Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: GUMC Stories